Natasha Hernday serves as Executive at PDL BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, Natasha Hernday has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 19, 2024 involved receiving (via award) 2,500 shares valued at $0.
Natasha Hernday currently holds 7,500 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Natasha Hernday has been a net neutral trader of PDLI stock. They have purchased $0 and sold $0 worth of shares.
Natasha Hernday's most recent insider trade was on Jul 19, 2024, when they sold 2,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 19, 2024 | JANX | $0 | Award | 1,231 | $N/A | Discretionary |
| May 15, 2024 | XOMA | $0 | Award | 3,035 | $N/A | Discretionary |
| Dec 15, 2020 | XOMA | $100.0K | Award | 4,000 | $25.00 | Discretionary |
| Aug 19, 2020 | PDLI | $0 | Award | 25,826 | $N/A | Discretionary |
| Jun 20, 2019 | PDLI | $0 | Award | 50,000 | $N/A | Discretionary |